Transcriptomics

Dataset Information

0

Expression data from glioblastoma derived xenograft and original glioblastoma tumors


ABSTRACT: Amplification of the epidermal growth factor receptor (EGFR, A0 for non-amplified and A1 for amplified) gene is one of the most common oncogenic alterations in glioblastoma (45%) making it a prime target for therapy. However, small molecule inhibitors of the EGFR tyrosine kinase showed disappointing efficacy in clinical trials for glioblastoma. Here we report expression data for 33 samples including 6 GBM derived xenografts (3 controls and 3 treated by tyrosine kinase inhibitor gefitinib) and 27 glioblastoma tumors (11 controls and 16 treated by tyrosine kinase inhibitor gefitinib). Note that T0, T1 and T2 treatment types mean that control, Gefitinib treatment and Gefitinib treatment (but not according to protocol schedule), respectively.

ORGANISM(S): Homo sapiens

PROVIDER: GSE279426 | GEO | 2024/10/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-08-23 | E-GEOD-74575 | biostudies-arrayexpress
2010-03-23 | E-GEOD-20854 | biostudies-arrayexpress
2010-03-13 | GSE20854 | GEO
2016-03-29 | E-GEOD-79688 | biostudies-arrayexpress
2014-01-01 | E-GEOD-34228 | biostudies-arrayexpress
2018-01-11 | GSE103155 | GEO
2019-11-25 | GSE139414 | GEO
2017-06-02 | GSE95590 | GEO
2017-06-02 | GSE95558 | GEO
2012-01-01 | E-GEOD-33483 | biostudies-arrayexpress